Private company

TAURIGA SCIENCES, INC.

American medicinal chemicals and botanical products company. Summary from the record

Last updated Oct 19, 2026.

Overview

$285.3KRevenue, fiscal 2021²

-$3.6MNet income, fiscal 2021³

IndustryMedicinal Chemicals & Botanical Products¹
HeadquartersWappingers Falls, New York¹
Incorporated inFL⁴
Business address4 Nancy Court, Suite 4, Wappingers Falls, Ny 12590⁴
Filer categoryNon-accelerated filer, Smaller reporting company⁴

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

43.0%Gross margin²

-1188.0%Operating margin³

-1271.0%Net margin³

21.7%Revenue growth, 2021²

-285.3%Return on equity³

-$2.6MFree cash flow³

Where the money goes

Where each dollar of revenue went, fiscal 2021

Research and developmentInterest

Cost of revenue11¢$162.6K
Research and development18¢$273.4K
Interest71¢$1.1M

Out of $285.3K in revenue.²³ The company lost money this year.

Financial statements

Revenue⁵⁶⁷³²$285.3K in 2021+197% since 2015

Gross profit⁵⁶⁷³²$122.7K in 2021+126% since 2015

Operating income⁸⁹⁶¹⁰⁷³-$3.4M in 2021−15% since 2015

Net income⁸⁹⁶¹⁰⁷³-$3.6M in 2021−29% since 2015

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Revenue	$96.2K⁵			$1.2K⁶	$57.1K⁷	$234.4K³	$285.3K²
Cost of revenue	$41.8K⁵			$715⁶	$37.1K⁷	$197.2K⁷	$162.6K³
Gross profit	$54.4K⁵			$473⁶	$20.0K⁷	$54.2K³	$122.7K²
Research and development	$78.9K⁸	$0⁸	$108.9K⁶	$10.1K¹⁰	$13.9K⁷	$6.9K³	$273.4K³
Operating income	-$4.0M⁸	-$2.0M⁹	-$1.5M⁶	-$1.9M¹⁰	-$1.1M⁷	-$2.0M³	-$3.4M³
Interest		$4.8K¹¹			$280.6K⁷	$902.2K³	$1.1M³
Net income	-$5.1M⁸	-$2.6M⁹	-$2.2M⁶	-$36.1K¹⁰	-$1.1M⁷	-$3.0M³	-$3.6M³
Earnings per share		$0.00⁹	$0.00⁹
Earnings per share (diluted)			-$0.00⁶	-$0.01¹⁰	-$0.02⁷	-$0.04⁷

Total assets⁸⁹⁶¹⁰⁷³$2.5M in 2021+594% since 2015

Total liabilities⁶¹⁰⁷³$1.2M in 2021−42% since 2017

Shareholders’ equity⁹⁶⁷³$1.3M in 2021

Cash⁹¹⁰⁷³$49.8K in 2021−76% since 2015

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Cash	$209.1K⁹		$18¹⁰	$12.3K¹⁰	$385.9K⁷	$5.3K³	$49.8K³
Current assets	$333.4K⁸	$3.2K⁹	$2.8K⁶	$686.3K¹⁰	$947.8K⁷	$607.9K³	$2.4M³
Total assets	$358.6K⁸	$10.2K⁹	$3.8K⁶	$688.8K¹⁰	$960.8K⁷	$643.5K³	$2.5M³
Current liabilities	$1.7M⁸	$2.3M⁹	$2.0M⁶	$318.6K¹⁰	$457.4K⁷	$942.7K³	$1.2M³
Total liabilities			$2.1M⁶	$393.6K¹⁰	$457.4K⁷	$951.7K³	$1.2M³
Shareholders’ equity	-$1.3M⁹	-$2.3M⁹	-$2.1M⁶	$295.3K⁷	$503.4K³	-$308.2K³	$1.3M³
Shares outstanding	899.0M shares⁸	1.4B shares⁸	2.1B shares⁹	4.1B shares⁶	72.9M shares¹⁰	145.3M shares⁷	287.9M shares³

Cash from operations⁸⁹⁶¹⁰⁷³-$2.6M in 2021+38% since 2015

Capital spending⁶¹⁰⁷³$16.1K in 2021+1389% since 2017

Free cash flow⁶¹⁰⁷³-$2.6M in 2021+294% since 2017

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Cash from operations	-$1.8M⁸	-$395.5K⁹	-$651.1K⁶	-$542.3K¹⁰	-$328.6K⁷	-$1.5M³	-$2.6M³
Capital spending			$1.1K⁶	$3.1K¹⁰	$12.4K⁷	$2.6K³	$16.1K³
Free cash flow			-$652.2K	-$545.4K	-$341.0K	-$1.5M	-$2.6M

Compare TAURIGA SCIENCES, INC. with another company

Leadership

Who has led TAURIGA SCIENCES, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

Chief financial officer

Chief operating officer

Stella M. Sung2013

201520202025

Chief executive officerStella M. Sung Jun 25, 2014 to Mar 30, 2015¹²
Chief executive officerSeth M. Shaw Oct 5, 2012 to May 27, 2021¹³
Chief financial officerKevin Patrick Lacey Jul 13, 2017 to Jul 13, 2017¹⁴
Chief financial officerGhalia Lahlou Apr 22, 2016 to Apr 22, 2016¹⁵
Chief financial officerBruce Harmon Oct 18, 2012 to Dec 31, 2012¹⁶
Chief operating officerStella M. Sung May 15, 2013 to Dec 13, 2013¹⁷

Board members and other officers (7)

Board memberChris Sferruzzo Apr 14, 2021 to Apr 14, 2021¹⁸
Board memberJames Rosati V. Apr 20, 2021 to Apr 20, 2021¹⁹
Board memberDavid L. Wolitzky Apr 22, 2016 to Apr 22, 2016²⁰
Board memberKeith Berman Apr 29, 2016 to Apr 29, 2016²¹
Board memberHingge Hsu Jan 27, 2015 to Apr 22, 2016²²
Board memberStella M. Sung May 15, 2013 to Mar 30, 2015¹⁷
Board memberSeth M. Shaw Oct 5, 2012 to May 27, 2021¹³

Former names

Immunovative, Inc.Jun 29, 2012 to Apr 8, 2013⁴
Novo Energies CorpJun 26, 2009 to Mar 29, 2012⁴
ATLANTIC WINE AGENCIES INCJun 29, 2004 to May 21, 2009⁴
ATLANTICWINE AGENCIES INCFeb 17, 2004 to Jun 2, 2004⁴
NEW ENGLAND ACQUISITIONS INCSep 25, 2001 to Feb 12, 2004⁴

Timeline

Jun 25, 2014New chief executive Stella M. Sung becomes CEO¹²
Oct 5, 2012New chief executive Seth M. Shaw becomes CEO¹³

Filings

9 filings to the SEC since October 2021: 2 quarterly reports, 1 major events, 6 other. The latest 9:

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTAURIGA SCIENCES, INC. filings on SEC EDGAR
2
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2021
3
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2021
4
SEC EDGARTAURIGA SCIENCES, INC. filings on SEC EDGAR
5
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2015
6
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2018
7
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2019
8
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2015
9
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2016
10
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2018
11
SEC EDGARTAURIGA SCIENCES, INC. 10-K for fiscal 2016
12
SEC EDGARStella M. Sung, Chief executive officer
13
SEC EDGARSeth M. Shaw, Chief executive officer
14
SEC EDGARKevin Patrick Lacey, Chief financial officer
15
SEC EDGARGhalia Lahlou, Chief financial officer
16
SEC EDGARBruce Harmon, Chief financial officer
17
SEC EDGARStella M. Sung, Chief operating officer
18
SEC EDGARChris Sferruzzo, Board member
19
SEC EDGARJames Rosati V., Board member
20
SEC EDGARDavid L. Wolitzky, Board member
21
SEC EDGARKeith Berman, Board member
22
SEC EDGARHingge Hsu, Board member